Fique a par da investigação científica de várias equipas portuguesas selecionadas pela European Society for Medical Oncology.

Posters

329PD | Survival of patients with synchronous and metachronous breast cancer and meningioma

Author(s): C. Ribeiro¹, L. Mascarenhas¹, J.P. Lavrador¹, A. Peralta¹, M. Valente²;

¹Lisboa, PT, ²Oxford, GB

Poster discussion session: sábado, 8 de outubro 2016 | 16:30 – 17:30 | Brussels

350P | Extended adjuvant temozolamide as prognostic factor of longer overall and progression-free survival in glioblastoma multiforme

Author(s): S. Póvoa, N. Tavares, M. Ribeiro, D. Azevedo, A. Coelho, A. Fernandes, A. Costa, C. Caeiro, B. Carvalho, P. Linhares, L. Osório, L. Castro, J. Fonseca, M. Damasceno; Porto, PT

domingo, 9 de outubro 2016|13:00 – 14:00 | Hall E

758P | Neutrophil to lymphocyte ratio (NLR) impact on the survival and response duration of patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA)

Author(s): A. Mansinho, D. Macedo, I. Fernandes, A. Quintela, L. Costa; Lisboa, PT

domingo, 9 de outubro 2016 | 13:00 – 14:00 | Hall E

988P | Waiting time to diagnosis and treatment of the head and neck cancer in four institutions in Portugal

Author(s): A. Castro , J. Febra , A. Coelho , M. Rocha , S. Lopes , H. Gouveia , A. Joaquim , F. Monteiro , T. Mota¹, A. Araujo2;

¹Porto, PT, ²Vila Real, PT, ³Santa Maria Da Feira, PT, ⁴Vila Nova De Gaia, PT

domingo, 9 de outubro 2016 | 13:00 – 14:00 | Hall E

1000P | Outcomes of critically ill head and neck cancer (HNC) patients (pts) admitted in medical intensive care units (mICU) after oncological treatments

Author(s): A.C. Freitas, M.T. Alexandre, I. Sargento, M. Ferreira, M. Ramos, A. Marques, A. Moreira; Lisboa, PT

domingo, 9 de outubro | 13:00 – 14:00 | Hall E

1013P | Cercival lymph node metastasis of squamous cell carcinoma of an unknown primary (SCCUP): A single institutional review

Author(s): J. Silva, M.T. Alexandre, D. Ferreira, M. Ramos, P. Pereira, N. Ferreira, I. Sargento, E. Netto, M. Magalhaes, M. Ferreira, A. Moreira; Lisboa, PT

domingo, 9 de outubro | 13:00 – 14:00 | Hall E

1454P | Impact of sepsis and organ dysfunction on cancer patients' mortality

Author(s): F. Pereira, S. Alves, J. Dias, I. Guerreiro, M. Silva, A. Afonso, P. Mergulhão, J. Savva-Bordalo, D. Pereira; Porto, PT

domingo, 9 de outubro | 13:00 – 14:00 | Hall E

1488P | Analysis of cancer outcomes after desensitization protocols in patients with metastatic disease

Author(s): C. Pulido, J. Caiado, A. Ferreira, I. Vendrell, A.L. Costa, A. Mendes, M.E. Pedro, N. Fernandes, L. Pestana, P. Almeida, C. Pinto, A. Quintela, L. Ribeiro, I. Fernandes, P. Filipe, R. Sousa, C. Abreu, D. Macedo, M. Barbosa, L. Costa; Lisboa, PT

domingo, 9 de outubro | 13:00 – 14:00 | Hall E

1303P | - Safety and effectiveness of interventions for malignant ascites with advanced cancer: Systematic review

Author(s): D. Martins-Branco¹, C. Ribeiro¹, B. Gomes²;

¹Lisboa, PT, ²London, GB

domingo, 9 de outubro | 13:00 – 14:00 | Hall E

Predictors of effectiveness of the use of steroidal aromatase inhibitors after progression on non-steroidal aromatase inhibitors in advanced breast cancer patients

Author(s): M.M. Ulrich de Menezes Pereira dos Santos, C. Cardoso, M. Sousa, S. Esteves, M. Brito, A. Moreira

Lisboa, PT

segunda, 10 de outubro 2016 | 13:00 – 14:00 | Hall E